
LINK . SPRINGER . COM {
}
Title:
All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells | BMC Cancer
Description:
Background The enrichment of cancer stem cell-like cells (CSCs) has been considered to be responsible for tumor progression after an initial response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in patients with non-small cell lung adenocarcinoma (NSCLC/ADC). CSCs with ALDH1A1bright /CD44high expression contribute to the TKIs resistance in NSCLC/ADC cells. All-trans retinoic acid (ATRA) has been shown to be a potential targeted therapy against CSCs due to its ability to inhibit ALDH1A1 activity. We therefore investigated whether ATRA could circumvent the resistance to improve the response to gefitinib in NSCLC/ADC cells. Methods Treatment of NSCLC/ADC A549 and H1650 cells with gefitinib enriched the gefitinib surviving cells (GSCs). The expression of ALDH1A1 and CD44 and the IC50 values for gefitinib were determined by flow cytometry (FCM) and crystal violet assay in GSCs and ATRA-treated GSCs, respectively. Using DEAB as the positive control, direct inhibitory effect of ATRA on ALDH1A1 activity was determined by ALDEFLUOR assay, Results GSCs showed higher expression of ALDH1A1 and CD44 and IC50 values for gefitinib than their respective parental cells, suggesting that gefitinib can lead to propagation of CSC-enriched gefitinib-resistant cells. Treatment with ATRA was found to significantly reduce the increased expression of ALDH1A1 and CD44 and the IC50 values for gefitinib in A549GSC and H1650GSC cells, and ATRA could directly inhibit active ALDH1A1 as compared to DEAB. Conclusion Our findings suggest that combination treatment with ATRA prevents gefitinib-induced enrichment of ALDH1A1bright/CD44high CSCs and enhances gefitinib-induced growth inhibition of NSCLC/ADC cells.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {š}
- Science
- Education
- Health & Fitness
Content Management System {š}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {š}
What is the average monthly size of link.springer.com audience?
š Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 8,177,289 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {šø}
The income method remains a mystery to us.
The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.
Keywords {š}
cancer, cells, cell, pubmed, article, gefitinib, lung, atra, resistance, cas, google, scholar, aldha, expression, acid, retinoic, nsclc, egfr, cscs, growth, stem, treatment, agsc, data, receptor, hgsc, egfrtkis, inhibition, rarβ, activity, nonsmall, central, mutation, factor, nsclcadc, fig, apoptosis, tumor, response, patients, celllike, kinase, control, acquired, alltrans, inhibitors, shown, therapy, showed, compared,
Topics {āļø}
n-[3-chloro-4-fluorophenyl]-7-methoxy-6-[3-morpholinopropoxy]quinazolin-4- amine egfr-tki-resistant aldh1a1bright/cd44high csc gadd153-ccaat-enhancing binding protein-β net/cancer-types/lung-cancer ccaat/enhancer-binding protein beta jun n-terminal kinase csc-enriched gefitinib-resistant cells csc cell-mediated resistance gsc-enriched gefitinib-resistant cells egfr-mutant lung cancers ccaat-enhancing binding protein drug-resistant cancer cells article download pdf small-cell lung cancer reduce csc-mediated resistance aldh1a1bright/cd44high cell population egfr-tkis exposure influences tyrosine kinase inhibitors therapeutic anti-csc trans retinoic acid trans-retinoic acid receptor class-selective retinoids retinoic acid receptor potential therapeutic targets egfr-tkis maintenance therapy tris/acetate/edta pcr cell-mediated resistance aldh1a1-negative cell population cancer therapies egfr/wnt signaling pathways retinoic acid signaling lung cancer stem aldehyde dehydrogenase inhibitors cancer stem cell cancer stem cell full access high atra levels quantitative fluorescence pcr gata-binding factor 6 retinoic acid receptors cell death dis cancer drug resistance short-term gefitinib treatment promising therapeutic strategy aldh1a1bright/cd44high cscs linked tumor stem cell cancer stemness induced cancer stem cells aldh/nrf2 signaling privacy choices/manage cookies
Schema {šŗļø}
WebPage:
mainEntity:
headline:All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
description:The enrichment of cancer stem cell-like cells (CSCs) has been considered to be responsible for tumor progression after an initial response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in patients with non-small cell lung adenocarcinoma (NSCLC/ADC). CSCs with ALDH1A1bright /CD44high expression contribute to the TKIs resistance in NSCLC/ADC cells. All-trans retinoic acid (ATRA) has been shown to be a potential targeted therapy against CSCs due to its ability to inhibit ALDH1A1 activity. We therefore investigated whether ATRA could circumvent the resistance to improve the response to gefitinib in NSCLC/ADC cells. Treatment of NSCLC/ADC A549 and H1650 cells with gefitinib enriched the gefitinib surviving cells (GSCs). The expression of ALDH1A1 and CD44 and the IC50 values for gefitinib were determined by flow cytometry (FCM) and crystal violet assay in GSCs and ATRA-treated GSCs, respectively. Using DEAB as the positive control, direct inhibitory effect of ATRA on ALDH1A1 activity was determined by ALDEFLUOR assay, GSCs showed higher expression of ALDH1A1 and CD44 and IC50 values for gefitinib than their respective parental cells, suggesting that gefitinib can lead to propagation of CSC-enriched gefitinib-resistant cells. Treatment with ATRA was found to significantly reduce the increased expression of ALDH1A1 and CD44 and the IC50 values for gefitinib in A549GSC and H1650GSC cells, and ATRA could directly inhibit active ALDH1A1 as compared to DEAB. Our findings suggest that combination treatment with ATRA prevents gefitinib-induced enrichment of ALDH1A1bright/CD44high CSCs and enhances gefitinib-induced growth inhibition of NSCLC/ADC cells.
datePublished:2020-04-15T00:00:00Z
dateModified:2020-04-15T00:00:00Z
pageStart:1
pageEnd:9
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12885-020-06818-0
keywords:
All-trans retinoic acid
ALDH1A1
CD44
EGFR tyrosine kinase inhibitors
Non-small cell lung adenocarcinoma
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig4_HTML.png
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wenxiu Yao
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Liyang Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huan Huang
affiliation:
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
type:Organization
type:Person
name:Xin Li
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Pinjia Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Kun Mi
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jia Cheng
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huifen Liu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Cuirong Gu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Lingxiao Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jianming Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
description:The enrichment of cancer stem cell-like cells (CSCs) has been considered to be responsible for tumor progression after an initial response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) in patients with non-small cell lung adenocarcinoma (NSCLC/ADC). CSCs with ALDH1A1bright /CD44high expression contribute to the TKIs resistance in NSCLC/ADC cells. All-trans retinoic acid (ATRA) has been shown to be a potential targeted therapy against CSCs due to its ability to inhibit ALDH1A1 activity. We therefore investigated whether ATRA could circumvent the resistance to improve the response to gefitinib in NSCLC/ADC cells. Treatment of NSCLC/ADC A549 and H1650 cells with gefitinib enriched the gefitinib surviving cells (GSCs). The expression of ALDH1A1 and CD44 and the IC50 values for gefitinib were determined by flow cytometry (FCM) and crystal violet assay in GSCs and ATRA-treated GSCs, respectively. Using DEAB as the positive control, direct inhibitory effect of ATRA on ALDH1A1 activity was determined by ALDEFLUOR assay, GSCs showed higher expression of ALDH1A1 and CD44 and IC50 values for gefitinib than their respective parental cells, suggesting that gefitinib can lead to propagation of CSC-enriched gefitinib-resistant cells. Treatment with ATRA was found to significantly reduce the increased expression of ALDH1A1 and CD44 and the IC50 values for gefitinib in A549GSC and H1650GSC cells, and ATRA could directly inhibit active ALDH1A1 as compared to DEAB. Our findings suggest that combination treatment with ATRA prevents gefitinib-induced enrichment of ALDH1A1bright/CD44high CSCs and enhances gefitinib-induced growth inhibition of NSCLC/ADC cells.
datePublished:2020-04-15T00:00:00Z
dateModified:2020-04-15T00:00:00Z
pageStart:1
pageEnd:9
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12885-020-06818-0
keywords:
All-trans retinoic acid
ALDH1A1
CD44
EGFR tyrosine kinase inhibitors
Non-small cell lung adenocarcinoma
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_Fig4_HTML.png
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wenxiu Yao
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Liyang Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huan Huang
affiliation:
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
type:Organization
type:Person
name:Xin Li
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Pinjia Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Kun Mi
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jia Cheng
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Huifen Liu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Cuirong Gu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Lingxiao Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Jianming Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:BMC Cancer
issn:
1471-2407
volumeNumber:20
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Wenxiu Yao
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Liyang Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Huan Huang
affiliation:
name:Wuming Hospital Affiliated to Guangxi Medical University
address:
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
type:PostalAddress
type:Organization
name:Xin Li
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Pinjia Wang
affiliation:
name:Medical School of University of Electronic Science and Technology of China
address:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Kun Mi
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Jia Cheng
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Huifen Liu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Cuirong Gu
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Lingxiao Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Jianming Huang
affiliation:
name:Sichuan Cancer Insititute
address:
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Medical oncology, Wuming Hospital Affiliated to Guangxi Medical University, Nanning, China
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Medical oncology, Sichuan Cancer Hospital, Medical School of University of Electronic Science and Technology of China, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
name:Department of Biochemistry & Molecular Biology, Sichuan Cancer Insititute, Chengdu, Peopleās Republic of China
External Links {š}(197)
- What's the total monthly financial gain of https://www.springernature.com/gp/authors?
- Profit of https://link.springernature.com/home/
- How much money does https://order.springer.com/public/cart generate?
- Financial intake of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
- Revenue of https://bmccancer.biomedcentral.com/about
- How much does https://submission.nature.com/new-submission/12885/3 bring in each month?
- How much revenue does https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics produce monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Statistics%20Approved%20by%20the%20Cancer.%20Net%20Editorial%20Board&publication_year=2019
- What's the financial intake of https://doi.org/10.1016%2Fj.ejca.2005.07.031?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16364841?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Mutations%20of%20the%20epidermal%20growth%20factor%20receptor%20in%20non-small%20cell%20lung%20cancer-search%20and%20destroy&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2005.07.031&volume=42&pages=17-23&publication_year=2006&author=Chan%2CSK&author=Gullick%2CWJ&author=Hill%2CME?
- What's the total monthly financial gain of https://doi.org/10.1200%2FJCO.2008.21.5541?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19738125 generate?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20placebo-%20controlled%2C%20phase%20II%20study%20of%20sequential%20erlotinib%20and%20chemotherapy%20as%20first-line%20treatment%20for%20advanced%20non-small-cell%20lung%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.21.5541&volume=27&pages=5080-5087&publication_year=2009&author=Mok%2CTS&author=Wu%2CYL&author=Yu%2CCJ&author=Zhou%2CC&author=Chen%2CYM&author=Zhang%2CL?
- How much revenue does https://doi.org/10.1056%2FNEJMoa040938 produce monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15118073
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Activating%20mutations%20in%20the%20epidermal%20growth%20factor%20receptor%20underlying%20responsiveness%20of%20non-small-cell%20lung%20cancer%20to%20gefitinib&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa040938&volume=350&pages=2129-2139&publication_year=2004&author=Lynch%2CTJ&author=Bell%2CDW&author=Sordella%2CR&author=Gurubhagavatula%2CS&author=Okimoto%2CRA&author=Brannigan%2CBW?
- How much income does https://doi.org/10.1126%2Fscience.1099314 have?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15118125?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=EGFR%20mutations%20in%20lung%20cancer%3A%20correlation%20with%20clinical%20response%20to%20gefitinib%20therapy&journal=Science.&doi=10.1126%2Fscience.1099314&volume=304&pages=1497-1500&publication_year=2004&author=Paez%2CJG&author=J%C3%A4nne%2CPA&author=Lee%2CJC&author=Tracy%2CS&author=Greulich%2CH&author=Gabriel%2CS?
- Learn about the earnings of https://doi.org/10.1158%2F1078-0432.CCR-06-0714
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17020982 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20epidermal%20growth%20factor%20receptor%20gene%20mutation%20in%20patients%20with%20non-small%20cell%20lung%20cancer%20and%20acquired%20resistance%20to%20gefitinib&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-0714&volume=12&pages=5764-5769&publication_year=2006&author=Kosaka%2CT&author=Yatabe%2CY&author=Endoh%2CH&author=Yoshida%2CK&author=Hida%2CT&author=Tsuboi%2CM net monthly?
- What's the income generated by https://doi.org/10.1016%2FS1470-2045%2809%2970364-X each month?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20022809 have monthly?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Gefitinib%20versus%20cisplatin%20plus%20docetaxel%20in%20patients%20with%20non-small-cell%20lung%20cancer%20harbouring%20mutations%20of%20the%20epidermal%20growth%20factor%20receptor%20%28WJTOG3405%29%3A%20an%20open%20label%2C%20randomised%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2809%2970364-X&volume=11&pages=121-128&publication_year=2010&author=Mitsudomi%2CT&author=Morita%2CS&author=Yatabe%2CY&author=Negoro%2CS&author=Okamoto%2CI&author=Tsurutani%2CJ
- https://doi.org/10.1056%2FNEJMoa0909530's revenue stream
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20573926
- http://scholar.google.com/scholar_lookup?&title=Gefitinib%20or%20chemotherapy%20for%20non-small-cell%20lung%20cancer%20with%20mutated%20EGFR&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0909530&volume=362&pages=2380-2388&publication_year=2010&author=Maemondo%2CM&author=Inoue%2CA&author=Kobayashi%2CK&author=Sugawara%2CS&author=Oizumi%2CS&author=Isobe%2CH income
- What's the financial gain of https://doi.org/10.1056%2FNEJMoa044238?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15728811 bring in each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=EGFR%20mutation%20and%20resistance%20of%20non-small-cell%20lung%20cancer%20to%20gefitinib&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa044238&volume=352&pages=786-792&publication_year=2005&author=Kobayashi%2CS&author=Boggon%2CTJ&author=Dayaram%2CT bring in?
- Find out how much https://doi.org/10.1158%2F1078-0432.CCR-12-2246 earns monthly
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23470965 make?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3630270?
- How much income does http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20tumor%20specimens%20at%20the%20time%20of%20acquired%20resistance%20to%20EGFR-TKI%20therapy%20in%20155%20patients%20with%20EGFR-mutant%20lung%20cancers&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-12-2246&volume=19&issue=8&pages=2240-2247&publication_year=2013&author=Yu%2CHA&author=Arcila%2CME&author=Rekhtman%2CN have?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30864018 income
- How much profit does http://scholar.google.com/scholar_lookup?&title=Strategies%20to%20overcome%20acquired%20resistance%20to%20EGFR%20TKI%20in%20the%20treatment%20of%20non-small%20cell%20lung%20cancer&journal=Clin%20Transl%20Oncol&doi=10.1007%2Fs12094-019-02075-1&volume=21&issue=10&pages=1287-1301&publication_year=2019&author=Gao%2CJ&author=Li%2CHR&author=Jin%2CC&author=Jiang%2CJH&author=Ding%2CJY generate?
- How much does https://doi.org/10.1002%2Fijc.28478 generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24105655 earn?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Therapy-%20induced%20enrichment%20of%20putative%20lung%20cancer%20stem-like%20cells&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.28478&volume=134&issue=6&pages=1270-1278&publication_year=2014&author=Freitas%2CDP&author=Teixeira%2CCA&author=Santos-Silva%2CF&author=Vasconcelos%2CMH&author=Almeida%2CGM?
- How much income is https://doi.org/10.1038%2Fcddis.2012.93 earning monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22825470's total income per month
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406592 generate?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Non-small%20cell%20lung%20cancer%20stem%2F%20progenitor%20cells%20are%20enriched%20in%20multiple%20distinct%20phenotypic%20subpopulations%20and%20exhibit%20plasticity&journal=Cell%20Death%20Dis&doi=10.1038%2Fcddis.2012.93&volume=3&publication_year=2012&author=Akunuru%2CS&author=James%20Zhai%2CQ&author=Zheng%2CY
- What is the monthly revenue of https://doi.org/10.1371%2Fjournal.pone.0014062?
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21124918
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988826 produce monthly?
- http://scholar.google.com/scholar_lookup?&title=Non-small%20cell%20lung%20cancer%20cells%20expressing%20CD44%20are%20enriched%20for%20stem%20cell-like%20properties&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0014062&volume=5&issue=11&publication_year=2010&author=Leung%2CEL&author=Fiscus%2CRR&author=Tung%2CJW&author=Tin%2CVP&author=Cheng%2CLC&author=Sihoe%2CAD's financial summary
- Learn how profitable https://doi.org/10.1158%2F0008-5472.CAN-12-4136 is on a monthly basis
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23542356 income
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506773 pull in?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Acquired%20resistance%20to%20EGFR%20inhibitors%20is%20associated%20with%20a%20manifestation%20of%20stem%20cell-like%20properties%20in%20cancer%20cells&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-12-4136&volume=73&issue=10&pages=3051-3061&publication_year=2013&author=Shien%2CK&author=Toyooka%2CS&author=Yamamoto%2CH?
- What's the income of https://doi.org/10.1093%2Fannonc%2Fmdx703?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29462254?
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454547?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20acquired%20resistance%20to%20first-%20and%20second-generation%20EGFR%20tyrosine%20kinase%20inhibitors&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdx703&volume=29&pages=i10-i19&publication_year=2018&author=Westover%2CD&author=Zugazagoitia%2CJ&author=Cho%2CBC&author=Lovly%2CCM&author=Paz-Ares%2CL?
- What's the monthly money flow for https://doi.org/10.1080%2F14737140.2017.1355243?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28701107 earn?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Overcoming%20resistance%20to%20EGFR%20tyrosine%20kinase%20inhibitors%20in%20lung%20cancer%2C%20focusing%20on%20non-T790M%20mechanisms&journal=Expert%20Rev%20Anticancer%20Ther&doi=10.1080%2F14737140.2017.1355243&volume=17&issue=9&pages=779-786&publication_year=2017&author=Suda%2CK&author=Rivard%2CCJ&author=Mitsudomi%2CT&author=Hirsch%2CFR
- How much revenue does https://doi.org/10.1158%2F0008-5472.CAN-13-3724 bring in?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25125655 produce monthly?
- How much money does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263272 generate?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=EGFR%20blockade%20enriches%20for%20lung%20cancer%20stem-like%20cells%20through%20Notch3-dependent%20signaling&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-3724&volume=74&pages=5572-5584&publication_year=2014&author=Arasada%2CRR&author=Amann%2CJM&author=Rahman%2CMA&author=Huppert%2CSS&author=Carbone%2CDP?
- What are the total earnings of https://doi.org/10.1371%2Fjournal.pone.0107142?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25216266
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162571's total income per month
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=ALDH1A1%20maintains%20ovarian%20cancer%20stem%20cell-like%20properties%20by%20altered%20regulation%20of%20cell%20cycle%20checkpoint%20and%20DNA%20repair%20network%20signaling&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0107142&volume=9&issue=9&publication_year=2014&author=Meng%2CE&author=Mitra%2CA&author=Tripathi%2CK?
- How much income does https://doi.org/10.1016%2Fj.biocel.2016.07.017 have?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27443528?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20ALDH1A1%20activity%20decreases%20expression%20of%20drug%20transporters%20and%20reduces%20chemotherapy%20resistance%20in%20ovarian%20cancer%20cell%20lines&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2Fj.biocel.2016.07.017&volume=78&pages=248-259&publication_year=2016&author=Januchowski%2CR&author=Wojtowicz%2CK&author=Sterzy%C5%BFska%2CK&author=Sosi%C5%BFska%2CP&author=Andrzejewska%2CM&author=Zawierucha%2CP&author=Nowicki%2CM&author=Zabel%2CM?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21818590 makes per month
- http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20aldehyde%20dehydrogenase%20%28ALDH%29%20activity%20reduces%20chemotherapy%20and%20radiationresistance%20of%20stem-like%20ALDHhiCD44%2B%20human%20breast%20cancer%20cells&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-011-1692-y&volume=133&issue=1&pages=75-87&publication_year=2012&author=Croker%2CAK&author=Allan%2CAL's revenue stream
- Profit of https://doi.org/10.1016%2Fj.tips.2019.08.002
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31515079
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Aldehyde%20dehydrogenase%20inhibitors%20for%20Cancer%20therapeutics&journal=Trends%20Pharmacol%20Sci&doi=10.1016%2Fj.tips.2019.08.002&volume=40&issue=10&pages=774-789&publication_year=2019&author=Dinavahi%2CSS&author=Bazewicz%2CCG&author=Gowda%2CR&author=Robertson%2CGP?
- What's the total monthly financial gain of https://doi.org/10.1038%2Fs41419-018-0903-4?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30166520 generate?
- How much income does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117306 have?
- http://scholar.google.com/scholar_lookup?&title=High%20NRF2%20level%20mediates%20cancer%20stem%20cell-like%20properties%20of%20aldehyde%20dehydrogenase%20%28ALDH%29-high%20ovarian%20cancer%20cells%3A%20inhibitory%20role%20of%20all-trans%20retinoic%20acid%20in%20ALDH%2FNRF2%20signaling&journal=Cell%20Death%20Dis&doi=10.1038%2Fs41419-018-0903-4&volume=9&issue=9&publication_year=2018&author=Kim%2CD&author=Choi%2CBH&author=Ryoo%2CIG&author=Kwak%2CMK's financial summary
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27942929?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Use%20of%20retinoic%20acid%2Faldehyde%20dehydrogenase%20pathway%20as%20potential%20targeted%20therapy%20against%20cancer%20stem%20cells&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-016-3213-5&volume=79&issue=2&pages=295-301&publication_year=2017&author=Moreb%2CJS&author=Ucar-Bilyeu%2CDA&author=Khan%2CA
- How much income does https://doi.org/10.1093%2Fjnci%2F91.12.1059 have?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10379969?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Expression%20of%20retinoid%20receptor%20genes%20and%20proteins%20in%20non-small-cell%20lung%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F91.12.1059&volume=91&issue=12&pages=1059-1066&publication_year=1999&author=Picard%2CE&author=Seguin%2CC&author=Monhoven%2CN&author=Rochette-Egly%2CC&author=Siat%2CJ&author=Borrelly%2CJ&author=Martinet%2CY&author=Martinet%2CN&author=Vignaud%2CJM?
- Learn about the earnings of https://doi.org/10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C88%3A%3AAID-IJC14%3E3.0.CO%3B2-9
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9426695 produce monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20RAR%20beta%20expression%20by%20RAR-and%20RXR-selective%20retinoids%20in%20human%20lung%20cancer%20cell%20lines%3A%20effect%20on%20growth%20inhibition%20and%20apoptosis%20induction&journal=Int%20J%20Cancer&doi=10.1002%2F%28SICI%291097-0215%2819980105%2975%3A1%3C88%3A%3AAID-IJC14%3E3.0.CO%3B2-9&volume=75&issue=1&pages=88-95&publication_year=1998&author=Li%2CY&author=Dawson%2CMI&author=Agadir%2CA&author=Lee%2CMO&author=Jong%2CL&author=Hobbs%2CPD&author=Zhang%2CXK?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27306217 earning monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Association%20between%20nuclear%20expression%20of%20retinoic%20acid%20receptor%20alpha%20and%20beta%20and%20clinicopathological%20features%20and%20prognosis%20of%20advanced%20non-small%20cell%20lung%20cancer&journal=Int%20J%20Clin%20Oncol&doi=10.1007%2Fs10147-016-1002-0&volume=21&issue=6&pages=1051-1061&publication_year=2016&author=Mu%C3%B1iz-Hern%C3%A1ndez%2CS&author=Huerta-Yepez%2CS&author=Hern%C3%A1ndez-Pedro%2CN&author=Ram%C3%ADrez-Tirado%2CLA&author=Aviles-Salas%2CA&author=Maldonado%2CA earn?
- https://doi.org/10.1111%2Fcas.12749's revenue stream
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26202045 earning monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4638008
- What's http://scholar.google.com/scholar_lookup?&title=Acquisition%20of%20cancer%20stem%20cell-like%20properties%20in%20non-small%20cell%20lung%20cancer%20with%20acquired%20resistance%20to%20afatinib&journal=Cancer%20Sci&doi=10.1111%2Fcas.12749&volume=106&pages=1377-1384&publication_year=2015&author=Hashida%2CS&author=Yamamoto%2CH&author=Shien%2CK's gross income?
- What's the income generated by https://doi.org/10.1158%2F1541-7786.MCR-08-0393 each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19276181 earn?
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255559?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Aldehyde%20dehydrogenase%201%20is%20a%20tumor%20stem%20cell-associated%20marker%20in%20lung%20cancer&journal=Mol%20Cancer%20Res&doi=10.1158%2F1541-7786.MCR-08-0393&volume=7&pages=330-338&publication_year=2009&author=Jiang%2CF&author=Qiu%2CQ&author=Khanna%2CA&author=Todd%2CNW&author=Deepak%2CJ&author=Xing%2CL earns monthly
- Explore the financials of https://doi.org/10.1016%2Fj.canlet.2012.08.021
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22935675?
- See how much http://scholar.google.com/scholar_lookup?&title=ALDH-positive%20lung%20cancer%20stem%20cells%20confer%20resistance%20to%20epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitors&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2012.08.021&volume=328&pages=144-151&publication_year=2013&author=Huang%2CCP&author=Tsai%2CMF&author=Chang%2CTH&author=Tang%2CWC&author=Chen%2CSY&author=Lai%2CHH makes per month
- How much income is https://doi.org/10.1158%2F0008-5472.CAN-13-3456 earning monthly?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24812274
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20cancer%20cell%20marker%20aldehyde%20dehydrogenase%20is%20required%20to%20maintain%20a%20drug-tolerant%20tumor%20cell%20subpopulation&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-3456&volume=74&pages=3579-3590&publication_year=2014&author=Raha%2CD&author=Wilson%2CTR&author=Peng%2CJ&author=Peterson%2CD&author=Yue%2CP&author=Evangelista%2CM&author=Wilson%2CC&author=Merchant%2CM&author=Settleman%2CJ?
- How much cash flow does https://doi.org/10.1002%2Fjcp.22417 have monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20836077 generate monthly?
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315372 earns monthly
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Retinoids%20regulate%20stem%20cell%20differentiation&journal=J%20Cell%20Physiol&doi=10.1002%2Fjcp.22417&volume=226&pages=322-330&publication_year=2011&author=Gudas%2CLJ&author=Wagner%2CJA?
- What's the monthly income of https://doi.org/10.1124%2Fjpet.104.072496?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15470086?
- How much does http://scholar.google.com/scholar_lookup?&title=Retinoic%20acid%20downregulates%20aldehyde%20dehydrogenase%20and%20increases%20cytotoxicity%20of%204-hydroperoxycyclophosphamide%20and%20acetaldehyde&journal=J%20Pharmacol%20Exp%20Ther&doi=10.1124%2Fjpet.104.072496&volume=312&pages=339-345&publication_year=2005&author=Moreb%2CJS&author=Gabr%2CA&author=Vartikar%2CGR&author=Gowda%2CS&author=Zucali%2CJR&author=Mohuczy%2CD rake in every month?
- How much profit does https://doi.org/10.1038%2Fs41467-018-03877-7 generate?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29643385
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895803 generate monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20cancer%20stem%20cell%20like%20cells%20by%20a%20synthetic%20retinoid&journal=Nat%20Commun&doi=10.1038%2Fs41467-018-03877-7&volume=9&publication_year=2018&author=Chen%2CJ&author=Cao%2CX&author=An%2CQ&author=Zhang%2CY&author=Li%2CK&author=Yao%2CW make?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Modulation%20of%20breast%20cancer%20stem%20cell%20marker%20CD44%20by%20all-trans-retinoic%20acid%20%28ATRA%29&journal=Cancer%20Res&volume=74&publication_year=2014&author=Kitadai%2CR&author=Bednarczyk%2CR&author=Tuli%2CN&author=Tiwari%2CRK?
- See how much https://doi.org/10.1016%2Fj.bcp.2008.10.011 makes per month
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18992716?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Retinoic%20acid%20modulates%20retinaldehyde%20dehydrogenase%201%20gene%20expression%20through%20the%20induction%20of%20GADD153-C%20%2FEBPbeta%20interaction&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2008.10.011&volume=77&pages=248-257&publication_year=2009&author=Elizondo%2CG&author=Medina-D%C3%ADaz%2CIM&author=Cruz%2CR&author=Gonzalez%2CFJ&author=Vega%2CL
- How much does https://doi.org/10.1074%2Fjbc.M004987200 pull in?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10995752 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Feedback%20inhibition%20of%20the%20retinaldehyde%20dehydrogenase%20gene%20ALDH1%20by%20retinoic%20acid%20through%20retinoic%20acid%20receptor%20alpha%20and%20CCAAT%2Fenhancer-binding%20protein%20beta&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M004987200&volume=275&pages=39747-39753&publication_year=2000&author=Elizondo%2CG&author=Corchero%2CJ&author=Sterneck%2CE&author=Gonzalez%2CFJ earn?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12012012 earn?
- How much income is http://scholar.google.com/scholar_lookup?&title=All%20trans%20retinoic%20acid%20enhances%20CDDP-induced%20apoptosis%3A%20modulation%20of%20the%20CDDP%20effect%20on%20cell%20cycle%20progression&journal=Int%20J%20Oncol&volume=20&pages=1289-1295&publication_year=2002&author=Jozan%2CS&author=Paute%2CS&author=Courtade-Sa%C3%AFdi%2CM&author=Juli%C3%A9%2CS&author=Vidal%2CS&author=Bugat%2CR&author=Valette%2CA earning monthly?
- Learn about the earnings of https://doi.org/10.1038%2Fsj.onc.1207040
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14724571 earns monthly
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=All-trans%20retinoic%20acid%20potentiates%20Taxotere%20induced%20cell%20death%20mediated%20by%20Jun%20N-terminal%20kinase%20in%20breast%20cancer%20cells&journal=Oncogene.&doi=10.1038%2Fsj.onc.1207040&volume=23&pages=426-433&publication_year=2004&author=Wang%2CQ&author=Wieder%2CR?
- How much money does https://doi.org/10.1016%2Fj.mam.2014.12.003 make?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Retinoic%20acid%20receptors%3A%20from%20molecular%20mechanisms%20to%20cancer%20therapy&journal=Mol%20Asp%20Med&doi=10.1016%2Fj.mam.2014.12.003&volume=41&pages=1-115&publication_year=2015&author=Masi%2CA&author=Leboffe%2CL&author=Marinis%2CE&author=Pagano%2CF&author=Cicconi%2CL&author=Rochette-Egly%2CC&author=Lo-Coco%2CF&author=Ascenzi%2CP&author=Nervi%2CC make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20507312 pull in monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907750 have monthly?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=All%20trans%20retinoic%20acid%20nanodisks%20enhance%20retinoic%20acid%20receptor%20mediated%20apoptosis%20and%20cell%20cycle%20arrest%20in%20mantle%20cell%20lymphoma&journal=Br%20J%20Haematol&volume=150&pages=158-169&publication_year=2010&author=Singh%2CAT&author=Evens%2CAM&author=Anderson%2CRJ&author=Beckstead%2CJA&author=Sankar%2CN&author=Sassano%2CA&author=Bhalla%2CS&author=Yang%2CS&author=Platanias%2CLC&author=Forte%2CTM&author=Ryan%2CRO&author=Gordon%2CLI have monthly?
- How much income is https://doi.org/10.1016%2FS0006-2952%2899%2900355-X earning monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10660115?
- How much does http://scholar.google.com/scholar_lookup?&title=Differential%20effects%20of%20retinoic%20acid%20on%20growth%20and%20apoptosis%20in%20human%20colon%20cancer%20cell%20lines%20associated%20with%20the%20induction%20of%20retinoic%20acid%20receptor%20beta&journal=Biochem%20Pharmacol&doi=10.1016%2FS0006-2952%2899%2900355-X&volume=59&pages=485-496&publication_year=2000&author=Lee%2CMO&author=Han%2CSY&author=Jiang%2CS&author=Park%2CJH&author=Kim%2CSJ earn?
- https://doi.org/10.1016%2Fj.phrs.2019.104331's revenue stream
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31254665 bring in?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066582 earn?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=The%20potential%20of%20retinoids%20for%20combination%20therapy%20of%20lung%20cancer%3A%20updates%20and%20future%20directions&journal=Pharmacol%20Res&doi=10.1016%2Fj.phrs.2019.104331&volume=147&publication_year=2019&author=Tripathi%2CSK&author=Pandey%2CK&author=Panda%2CM&author=Spinella%2CMJ&author=Rengasamy%2CKR&author=Biswal%2CBK?
- Find out how much https://doi.org/10.1093%2Fcarcin%2Fbgi006 earns monthly
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15618235?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Comprehensive%20expression%20analysis%20of%20retinoic%20acid%20receptors%20and%20retinoid%20X%20receptors%20in%20non-small%20cell%20lung%20cancer%3A%20implications%20for%20tumor%20development%20and%20prognosis&journal=Carcinogenesis.&doi=10.1093%2Fcarcin%2Fbgi006&volume=26&pages=525-530&publication_year=2005&author=Brabender%2CJ&author=Metzger%2CR&author=Salonga%2CD&author=Danenberg%2CKD&author=Danenberg%2CPV&author=H%C3%B6lscher%2CAH&author=Schneider%2CPM
- How much money does https://doi.org/10.1016%2FS1359-6349%2803%2900010-7 generate?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Retinoids%20and%20retinoic%20acid%20receptor%20in%20cancer&journal=Eur%20J%20Cancer%20Suppl&doi=10.1016%2FS1359-6349%2803%2900010-7&volume=1&pages=13-18&publication_year=2003&author=Lei%2CM&author=Th%C3%A9%2CH bring in?
- What's the total monthly financial gain of https://doi.org/10.1093%2Fjnci%2F89.9.624?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9150186's gross income?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Suppression%20of%20nuclear%20retinoic%20acid%20receptor%20%CE%B2%20in%20non-small%20cell%20lung%20cancer%20in%20vivo%3A%20implications%20in%20lung%20cancer%20development&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F89.9.624&volume=89&pages=624-629&publication_year=1997&author=Xu%2CXC&author=Sozzi%2CG&author=Lee%2CJS&author=Lee%2CJJ&author=Pastorino%2CU&author=Pilotti%2CS&author=Kurie%2CJM&author=Hong%2CWK&author=Lotan%2CR making per month?
- How much profit does https://doi.org/10.1038%2Fs41598-017-05047-z make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28684780 make?
- How profitable is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500497?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Retinoic%20Acid%20affects%20Lung%20Adenocarcinoma%20growth%20by%20inducing%20differentiation%20via%20GATA6%20activation%20and%20EGFR%20and%20Wnt%20inhibition&journal=Sci%20Rep&doi=10.1038%2Fs41598-017-05047-z&volume=7&publication_year=2017&author=Zito%2CG&author=Naselli%2CF&author=Saieva%2CL&author=Raimondo%2CS&author=Calabrese%2CG&author=Guzzardo%2CC&author=Forte%2CS&author=Rolfo%2CC&author=Parenti%2CR&author=Alessandro%2CR?
- What's https://citation-needed.springer.com/v2/references/10.1186/s12885-020-06818-0?format=refman&flavour=references's gross income?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wenxiu%20Yao earn?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wenxiu%20Yao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Liyang%20Wang make?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Liyang%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huan%20Huang?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huan%20Huang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xin%20Li generate?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xin%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Pinjia%20Wang bring in?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Pinjia%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kun%20Mi have?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kun%20Mi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jia%20Cheng make?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jia%20Cheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huifen%20Liu bring in each month?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huifen%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cuirong%20Gu
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cuirong%20Gu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lingxiao%20Huang?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lingxiao%20Huang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jianming%20Huang?
- Find out how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jianming%20Huang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earns monthly
- How much does https://static-content.springer.com/esm/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_MOESM1_ESM.jpg pull in?
- What's the revenue for https://static-content.springer.com/esm/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_MOESM2_ESM.jpg?
- https://static-content.springer.com/esm/art%3A10.1186%2Fs12885-020-06818-0/MediaObjects/12885_2020_6818_MOESM3_ESM.jpg's financial summary
- See how much http://creativecommons.org/licenses/by/4.0/ makes per month
- http://creativecommons.org/publicdomain/zero/1.0/'s total income per month
- What's the financial intake of https://s100.copyright.com/AppDispatchServlet?title=All-trans%20retinoic%20acid%20reduces%20cancer%20stem%20cell-like%20cell-mediated%20resistance%20to%20gefitinib%20in%20NSCLC%20adenocarcinoma%20cells&author=Wenxiu%20Yao%20et%20al&contentID=10.1186%2Fs12885-020-06818-0©right=The%20Author%28s%29&publication=1471-2407&publicationDate=2020-04-15&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0?
- https://crossmark.crossref.org/dialog/?doi=10.1186/s12885-020-06818-0 income
- https://citation-needed.springer.com/v2/references/10.1186/s12885-020-06818-0?format=refman&flavour=citation's financial summary
- Earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- What's the financial gain of https://www.springernature.com/gp/products?
- What is the monthly revenue of https://www.springernature.com/gp/librarians?
- Find out how much https://www.springernature.com/gp/societies earns monthly
- How much does https://www.springernature.com/gp/partners net monthly?
- How much profit does https://www.springer.com/ generate?
- https://www.nature.com/'s revenue stream
- How much does https://www.biomedcentral.com/ earn?
- What's the monthly income of https://www.palgrave.com/?
- How much income does https://www.apress.com/ have?
- How much revenue does https://www.springernature.com/gp/legal/ccpa bring in?
- What's the monthly income of https://www.springernature.com/gp/info/accessibility?
- How much income does https://support.springernature.com/en/support/home have?
- How much profit does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations generate?
- What is the monthly revenue of https://www.springernature.com/?
Analytics and Tracking {š}
- Google Tag Manager
Libraries {š}
- Clipboard.js
- Prism.js
CDN Services {š¦}
- Crossref